Works matching DE "RIVASTIGMINE"
Results: 90
Directed Evolution and Immobilization of Lactobacillus brevis Alcohol Dehydrogenase for Chemo‐Enzymatic Synthesis of Rivastigmine.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400454
- By:
- Publication type:
- Article
Concise Synthesis of Chiral Tricyclic Lactams by Tandem Dynamic Kinetic Asymmetric Reductive Amination/Lactamization Using Ammonium Salts.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 25, p. 1, doi. 10.1002/ange.202303868
- By:
- Publication type:
- Article
Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.
- Published in:
- Neurological Sciences, 2015, v. 36, n. 3, p. 457, doi. 10.1007/s10072-014-2002-3
- By:
- Publication type:
- Article
Treatment of pediatric antimuscarinic delirium with oral rivastigmine.
- Published in:
- Oxford Medical Case Reports, 2023, v. 2023, n. 9, p. 1, doi. 10.1093/omcr/omad096
- By:
- Publication type:
- Article
Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Neuropsychobiology, 2019, v. 78, n. 4, p. 200, doi. 10.1159/000501210
- By:
- Publication type:
- Article
No interaction between rivastigmine and citalopram on memory and novelty processing in healthy human volunteers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Acetylcholine and Rivastigmine as Corrosion Inhibitors of Cu -- Sn - Zn -- Pb Alloy in Hydrochloric Acid Environment: DFT & Electrochemical Approach.
- Published in:
- Journal of Applied Sciences & Environmental Management, 2021, v. 25, n. 8, p. 1441, doi. 10.4314/jasem.v25i8.24
- By:
- Publication type:
- Article
Donepezil as a safe alternative treatment after maculo‐papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.
- Published in:
- Psychogeriatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1111/j.1479-8301.2012.00403.x
- By:
- Publication type:
- Article
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
- Published in:
- Psychogeriatrics, 2012, v. 12, n. 3, p. 165, doi. 10.1111/j.1479-8301.2011.00400.x
- By:
- Publication type:
- Article
Correction: Rivastigmine attenuates the Alzheimer's disease related protein degradation and apoptotic neuronal death signaling.
- Published in:
- Biochemical Journal, 2022, v. 479, n. 11, p. 1147, doi. 10.1042/BCJ20200754_COR
- Publication type:
- Article
Changes in Alcohol Consumption and Risk of Dementia in a Nationwide Cohort in South Korea.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e2254771, doi. 10.1001/jamanetworkopen.2022.54771
- By:
- Publication type:
- Article
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071510
- By:
- Publication type:
- Article
HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine.
- Published in:
- Biomedicines, 2022, v. 10, n. 4, p. 867, doi. 10.3390/biomedicines10040867
- By:
- Publication type:
- Article
Alzheimer Disease.
- Published in:
- Psychiatric Times, 2023, v. 40, n. 3, p. 7
- Publication type:
- Article
The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16142
- By:
- Publication type:
- Article
ISMP Adverse Drug Reactions: Adalimumab-Induced Aseptic Meningitis Pill Desiccant -Induced Acute Hypoxic Respiratory Failure Rivastigmine Patch -Induced Angioedema Acute Liver Failure Due to Etodolac Severe Cognitive Impairment Due to High Free Valproic Acid Levels
- Published in:
- Hospital Pharmacy, 2018, v. 53, n. 5, p. 292, doi. 10.1177/0018578718794518
- By:
- Publication type:
- Article
New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation.
- Published in:
- BMC Chemistry, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13065-024-01235-x
- By:
- Publication type:
- Article
Evaluation of donepezil and rivastigmine administration on the cognitive deficits induced by electroconvulsive therapy: a randomized, double-blind clinical trial.
- Published in:
- Family Medicine & Primary Care Review, 2019, v. 21, n. 3, p. 243, doi. 10.5114/fmpcr.2019.88383
- By:
- Publication type:
- Article
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 7, p. 642, doi. 10.3390/cells13070642
- By:
- Publication type:
- Article
Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1343650
- By:
- Publication type:
- Article
Determination of Alzheimer's Drugs in a Human Urine Sample by Different Chemometric Methods: Chemometric Determination of Alzheimer's Drugs.
- Published in:
- International Journal of Analytical Chemistry, 2024, v. 2024, p. 1, doi. 10.1155/2024/5535816
- By:
- Publication type:
- Article
Cognitive Benefit of Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
- Published in:
- Neurology Alert, 2021, v. 40, n. 6, p. 1
- By:
- Publication type:
- Article
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 4, p. 9, doi. 10.1002/pu.31151
- Publication type:
- Article
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review.
- Published in:
- Drug Development Research, 2023, v. 84, n. 8, p. 1624, doi. 10.1002/ddr.22113
- By:
- Publication type:
- Article
Dementia Drugs and Age-Related Macular Degeneration.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Improvement in delirium and visuospatial function after rivastigmine in antimuscarinic toxicity: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease.
- Published in:
- Parkinson's Disease (20420080), 2023, p. 1, doi. 10.1155/2023/6667339
- By:
- Publication type:
- Article
Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis.
- Published in:
- Age & Ageing, 2023, v. 52, n. 6, p. 1, doi. 10.1093/ageing/afad091
- By:
- Publication type:
- Article
Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
- Published in:
- Journal of Medical Toxicology, 2023, v. 19, n. 2, p. 219, doi. 10.1007/s13181-022-00925-z
- By:
- Publication type:
- Article
A Novel Formulation: Donepezil Patch.
- Published in:
- Senior Care Pharmacist, 2023, v. 38, n. 7, p. 300, doi. 10.4140/TCP.n.2023.300
- By:
- Publication type:
- Article
Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study.
- Published in:
- Geriatrics & Gerontology International, 2019, v. 19, n. 7, p. 571, doi. 10.1111/ggi.13644
- By:
- Publication type:
- Article
Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine.
- Published in:
- Advanced Pharmaceutical Bulletin, 2020, v. 10, n. 1, p. 20, doi. 10.15171/apb.2020.003
- By:
- Publication type:
- Article
Development and Characterization of Rivastigmine Hydrogen Tartrate Elementary Osmotic Tablets.
- Published in:
- International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 1, p. 239, doi. 10.5530/ijpi.14.1.30
- By:
- Publication type:
- Article
Analytical Method Development and Validation of Rivastigmine in its Pure and Pharmaceutical Dosage form Using UPLC.
- Published in:
- International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 3, p. 595, doi. 10.5530/ijpi.13.3.074
- By:
- Publication type:
- Article
Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review.
- Published in:
- East Asian Archives of Psychiatry, 2024, v. 34, n. 2, p. 29, doi. 10.12809/eaap2353
- By:
- Publication type:
- Article
Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies.
- Published in:
- Materials (1996-1944), 2021, v. 14, n. 21, p. 6291, doi. 10.3390/ma14216291
- By:
- Publication type:
- Article
FDA-Approved Drugs to Treat Dementia.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2024, v. 62, n. 4, p. 5, doi. 10.3928/02793695-20240228-79
- Publication type:
- Article
Opposite changes in blood pressure and pulse rate in two patients with distigmine and rivastigmine intoxication.
- Published in:
- JA Clinical Reports, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40981-020-00323-w
- By:
- Publication type:
- Article
Rivastigmine Transdermal Patch 13.3 mg/24 h: A Review of Its Use in the Management of Mild to Moderate Alzheimer's Dementia.
- Published in:
- Drugs & Aging, 2014, v. 31, n. 8, p. 639, doi. 10.1007/s40266-014-0197-x
- By:
- Publication type:
- Article
Donepezil and Rivastigmine: Pharmacokinetic Profile and Brain-targeting After Intramuscular Administration in Rats.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2020, v. 19, n. 3, p. 95, doi. 10.22037/ijpr.2019.1100723
- By:
- Publication type:
- Article
Characteristics of patients with Alzheimer's disease who switch to rivastigmine transdermal patches in routine clinical practice.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 47, doi. 10.2147/PPA.S38719
- By:
- Publication type:
- Article
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10810, doi. 10.3390/ijms241310810
- By:
- Publication type:
- Article
Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6004, doi. 10.3390/ijms23116004
- By:
- Publication type:
- Article
Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040752
- By:
- Publication type:
- Article
The Influence of an Acute Administration of Cannabidiol or Rivastigmine, Alone and in Combination, on Scopolamine-Provoked Memory Impairment in the Passive Avoidance Test in Mice.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 6, p. 809, doi. 10.3390/ph17060809
- By:
- Publication type:
- Article
The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 11, p. 1136, doi. 10.3390/ph14111136
- By:
- Publication type:
- Article
The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.
- Published in:
- PLoS ONE, 2023, v. 18, n. 6, p. 1, doi. 10.1371/journal.pone.0286386
- By:
- Publication type:
- Article
The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
- Published in:
- BMC Neurology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2377-13-188
- By:
- Publication type:
- Article